Battlefield Acupuncture Points and What They Do

Battlefield Acupuncture, usually called BFA, is a protocol that uses five specific points on the outer ear to reduce pain quickly, often within minutes. Developed by Air Force physician Richard Niemtzow for use in combat and field-medicine settings, BFA has become one of the most widely taught acupuncture techniques in the U.S. military and Veterans Affairs health systems.¹ The evidence behind it, though, is more complicated than the protocol’s growing popularity might suggest.

The Five Points and Where They Sit on the Ear

BFA targets five points on each ear, needled in a specific sequence. The protocol calls for small, semi-permanent gold or titanium Aiguille Semi-Permanente (ASP) needles pressed into the cartilage at each site. The five points, treated in order, are:

Cingulate Gyrus: Located on the upper portion of the ear’s outer wall (the antihelix), this point is named after the brain region involved in processing the emotional dimension of pain. It is typically the first point needled.
Thalamus: Found on the inner wall of the antihelix, slightly below the Cingulate Gyrus point. The thalamus is a relay station in the brain that routes sensory signals, including pain, to higher processing areas.
Omega 2: Situated on the triangular fossa, the hollow near the top of the ear. This point is associated with calming and modulating brain activity.
Point Zero: Positioned on the notch of the helix root, roughly where the ear’s cartilage ridge begins to curve inward. In auricular therapy traditions, this point is considered a homeostatic balancer that returns the body toward a baseline state.
Shen Men: Located at the apex of the triangular fossa, near the top of the ear. Sometimes translated as “Spirit Gate,” this is one of the most widely used ear acupuncture points across many traditions and is associated with relaxation and anxiety reduction.

The clinician begins with the Cingulate Gyrus point on one ear, checks whether the patient’s pain has changed, then moves to the same point on the opposite ear. This alternating pattern continues through all five points. If pain drops to an acceptable level partway through, the remaining points are left untreated. In practice, providers in VA and military settings insert semi-permanent needles at these five points as part of a rapid protocol.² The tiny ASP needles stay embedded in the ear for several days before falling out on their own.

Why Ear Needling Might Reduce Pain

The ear is densely innervated by several cranial nerves, most critically the auricular branch of the vagus nerve. The vagus nerve runs from the brainstem through the neck and into the chest and abdomen, connecting to systems that regulate heart rate, digestion, inflammation, and mood. The concha, the bowl-shaped depression closest to the ear canal, has especially rich vagal innervation. While BFA points are distributed across different parts of the ear rather than clustered in the concha, the general principle is that stimulating auricular nerves can send signals into the brainstem and from there into pain-processing regions.

Recent animal research has started to map out a specific circuit that could explain ear-based pain relief. A 2025 study in mice with neuropathic pain found that electrical stimulation of the concha triggered analgesia through a pathway running from the ear to the brainstem’s nucleus of the solitary tract, then to the periaqueductal gray, a region that activates the brain’s descending pain-inhibition system.³ That descending system works like a volume knob for pain signals traveling up the spinal cord: when it activates, it dampens those signals before they reach conscious awareness. Whether this same circuit is engaged by BFA’s specific needle points in humans remains an open question, and researchers have flagged the need for neuroimaging and molecular studies to map the mechanism in people.⁴

What the Emergency Department Evidence Shows

BFA has been tested most frequently in emergency departments, where patients arrive in acute pain and providers are looking for alternatives to opioid injections. A randomized trial comparing BFA to standard pharmacologic treatment for low back pain in the ED found that patients who received BFA had a larger average drop in pain scores than those who received standard medication, with a difference of about 12 points on a 100-point visual scale.⁵ That is a modest but real difference, roughly the gap between describing your pain as a 5 versus a 4 out of 10.

Another ED trial compared BFA head-to-head with ketorolac, a commonly used injectable anti-inflammatory drug. The two treatments produced similar reductions in pain scores, with no statistically significant difference between them. Both resulted in what clinicians consider meaningful drops in pain for patients who arrived with severe or very severe pain.⁶ On the surface, matching an established pain medication sounds promising. But matching a drug is only meaningful if we know BFA beats doing nothing, and that is where the picture gets murkier.

A systematic review of randomized controlled trials on BFA in emergency settings concluded that while BFA appears safe and could serve as a useful add-on to standard care, the existing studies are too few and too methodologically limited to draw strong conclusions about effectiveness.⁷ Small sample sizes, inconsistent blinding, and variations in how pain was measured across trials make it hard to separate genuine analgesic effects from the expectation and ritual effects that come with any hands-on treatment.

The Sham-Control Problem

The thorniest issue in BFA research is what happens when you compare BFA to a convincing sham. In standard drug trials, you give one group the real pill and the other a sugar pill. For acupuncture, the equivalent is placing needles in locations that should have no therapeutic effect. This is harder than it sounds because inserting any needle into the ear stimulates nerves, so even a “wrong” placement can produce some degree of nerve activation.

A systematic review and meta-analysis that pooled data from randomized controlled trials found no significant improvement in pain intensity when BFA was compared to no intervention, usual care, sham BFA, or delayed BFA. The authors described BFA as safe, quick to learn, and mainly used for acute pain, but concluded that the evidence did not show significant efficacy for adults with pain compared to control groups.⁸ The studies included in that meta-analysis had poor methodological quality, making it difficult to know whether the null result reflects a genuinely ineffective technique or simply underpowered and poorly designed trials.

A separate randomized study of modified BFA in patients recovering from lower-extremity surgery found no differences in pain scores, opioid use, or quality of life between the BFA group and the control group at any time point, across 233 patients followed over 26 months.⁹ This is one of the larger and longer trials in the BFA literature, and its flat result carries weight.

The honest reading of the controlled evidence is that BFA’s pain-relieving effects have not been clearly separated from placebo responses. That does not necessarily mean it is useless in clinical practice, since a reliable placebo-level response with minimal side effects has genuine value in certain settings. But it does mean the specific ear points and their supposed neurological targets may not matter as much as the overall experience of receiving an attentive, physical treatment.

Chronic Pain and the Opioid Question

Beyond the emergency department, BFA has attracted attention as a potential tool for managing chronic pain and reducing opioid dependence, particularly in the VA system. Providers who use BFA report perceived advantages including simultaneous pain control and opioid reduction, offering hope to patients whose pain has not responded to conventional treatments, and providing a treatment option for patients with substance use disorders.² Those are perceptions from clinicians who have incorporated BFA into their practice, and they reflect genuine enthusiasm.

The measured outcomes are less encouraging. A study of BFA for chronic pain management in patients already on long-term opioid therapy found that about two-thirds of patients experienced an immediate drop of roughly 1.3 points on a 10-point pain scale right after the procedure. But over the following months, the study found no significant sustained decreases in pain and no significant changes in the average number of opioids patients used across the nine months analyzed.¹⁰ In other words, BFA gave a brief, real drop in pain during and just after the session, but it did not translate into lasting relief or reduced medication use. The study’s authors called for larger randomized controlled trials to properly assess these effects.

The military and VA health systems have invested heavily in training programs for BFA partly to address the opioid crisis, with large cross-agency collaborations designed to build capacity for non-drug pain management.¹¹ The gap between the institutional investment and the evidence base is one of the more contentious aspects of BFA’s story. Advocates argue that waiting for perfect evidence while patients suffer is unreasonable; skeptics point out that scaling up a treatment before rigorous proof exists is a recipe for entrenching practices that may not work.

What Patients Actually Report

The largest look at patient-reported outcomes comes from a VA dataset covering over 11,000 veterans who received BFA in routine clinical care. The average pain score before treatment was about 6.3 on a 10-point scale, dropping to roughly 3.8 afterward, an average decrease of 2.5 points. About 79% of veterans reported some decrease in pain scores with their initial treatment. When measured against a threshold for clinically meaningful improvement, roughly 62% of veterans cleared that bar at their first session, and about 43% experienced what qualifies as a substantial improvement.¹²

Those numbers look impressive, but they come with an important caveat: this was observational data, not a controlled trial. There was no sham group, no blinding, and patients knew exactly what they were receiving. Pain scores collected immediately after a treatment session in a clinical setting, where a provider has just paid close attention to you and done something physical to try to help, will naturally include a hefty contribution from expectation, therapeutic relationship, and regression to the mean. The 2.5-point average drop is real as a patient experience, but it cannot be attributed to the needle placement specifically.

How Providers Learn BFA

One reason BFA has spread so quickly is that the protocol is simple enough to teach in a single session. A study of resident physicians who completed BFA training found that the training was effective at imparting skills and that residents had favorable attitudes toward the technique afterward, though only a minority planned to use it regularly in their own practice.¹³ A separate study looked at a single BFA training session for geriatric and palliative care providers and found sustained knowledge retention and increased confidence at both one week and three months after training. More than half the participants went on to pursue formal credentialing to offer BFA at their institutions.¹⁴

This ease of training is a double-edged sword. On one hand, it means BFA can be deployed widely without requiring years of traditional acupuncture education, which appeals to military medics and primary-care providers who need tools they can use immediately. On the other hand, some practitioners of traditional auricular acupuncture argue that precisely locating ear points requires deep familiarity with ear anatomy and ongoing practice. Proponents of detailed ear cartography have emphasized that auricular medicine works well only when points are located with precision, which implies that a brief training session may not be enough to get consistent results.

Adaptations Beyond Needles

Not every patient or setting is suited to embedded metal needles. A recent pilot study explored a variation called battlefield acupressure, which uses small beads taped to the same five ear points instead of needles. The study tested this approach in both pediatric and adult emergency department patients. In a combined group of 31 patients, mean pain scores dropped from about 7.6 to roughly 3.4 on a 10-point scale, with a median time to lowest pain of about 32 minutes. No adverse events were reported.¹⁵ The pediatric patients ranged in age from 8 to 19 and presented mostly with headaches and abdominal pain.

This acupressure variant is appealing for children, needle-phobic patients, and settings where infection control makes embedded needles impractical. But it faces the same evidence gap as standard BFA: there was no control group in this pilot, so the large pain reductions could reflect the passage of time, the attention of a provider, or the self-limiting nature of many ED pain complaints. Still, a non-invasive, side-effect-free option for children in pain has obvious practical appeal, and researchers have called for controlled trials to follow up.

Where the Research Is Headed

The BFA field sits at an unusual juncture. The technique has been adopted widely across military and VA health systems, codified into training curricula, and embraced by thousands of providers. But the controlled evidence remains thin and largely unconvincing when sham treatments are included. Researchers have proposed three priorities to resolve this tension: mechanistic studies using neuroimaging and molecular techniques to identify whether BFA engages specific brain circuits, expanded military-civilian collaborations to generate larger trial populations, and technological integrations such as laser-acupuncture hybrids and artificial intelligence-assisted point localization.⁴

AI-assisted point localization is an interesting direction because one of the long-standing criticisms of auricular acupuncture is the difficulty of identifying the “right” spot consistently. Ear anatomy varies from person to person, and small differences in needle placement may change which nerves are stimulated. If the specific points matter for the therapeutic effect, finding them reliably is essential. If the specific points do not matter, that would tell us something equally important about what BFA is actually doing. Either way, the technology could bring a new kind of rigor to a field that has so far relied heavily on anatomical diagrams and trained fingertips.